NURO - NeuroMetrix Inc.

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• NeuroMetrix GAAP EPS of -$1.43, revenue of $1.32B
• NeuroMetrix announces review of strategic options for business growth
• NeuroMetrix announces one-for-eight reverse stock split
• NeuroMetrix reports Q3 results
• NeuroMetrix GAAP EPS of -$0.19, revenue of $1.66M
• NeuroMetrix announces sales force expansion for Quell Fibromyalgia
• NeuroMetrix GAAP EPS of -$0.20, revenue of $1.7M
• NeuroMetrix GAAP EPS of -$0.09, revenue of $1.84N
• NeuroMetrix reports Q3 results
• NeuroMetrix stock dips as Q2 net loss widens, revenue falls Y/Y
• NeuroMetrix GAAP EPS of -$0.17, revenue of $2.1M
• NeuroMetrix wins approval of neuromodulation device for fibromyalgia; shares up 42%
• NeuroMetrix GAAP EPS of -$0.14, revenue of $2.3M
• NeuroMetrix reports Q4 results
• NeuroMetrix surges on FDA Breakthrough Designation for neurostimulation technology
• NeuroMetrix shares fall after wider Q3 net loss
• NeuroMetrix reports Q3 results
• NeuroMetrix submits FDA De Novo request for neurostimulation device Quell
• Infinity Pharmaceuticals, Grove leads healthcare gainers; Dyadic, EyeGate Pharmaceuticals among major losers
• NeuroMetrix gains on trial results of neurostimulation device Quell for fibromyalgia